Fig. 5From: 177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatmentMIP of [177Lu]BPAMD, [177Lu]BPPED, and [177Lu]DOTA(MBP)2 in Wistar rats after 8 days of single intravenous injection, respectivelyBack to article page